Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Danske Invest-Bioteknologi Fund

+ Add to Watchlist

DANIBIO:DC

304.6000 DKK 6.0000 2.01%

As of 11:20:00 ET on 01/30/2015.

Snapshot for Danske Invest-Bioteknologi Fund (DANIBIO)

Open: 302.4000 High - Low: 308.8000 - 301.3000 Primary Exchange: Copenhagen
Volume: 45,297 52-Week Range: 164.1000 - 311.0000 Beta vs BTK: 0.9621

ETF Chart for DANIBIO

No chart data available.
  • DANIBIO:DC 304.6000
  • 1D
  • 1M
  • 1Y
298.6000
Interactive DANIBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DANIBIO

Danske Invest Bioteknologi Fund is an open-end fund registered in Denmark. The Fund's objective is capital appreciation, and to outperform NASDAQ's biotech-index(NBI). The Fund invests worldwide in equity of biotechnology companies, and companies closely related to the biotechnology sector.

Inception Date: 2000-05-26 Telephone: 45-3333-7171
Managers: -
Web Site: www.danskeinvest.dk

Fundamentals for DANIBIO

NAV (on 2015-01-30) 300.2000
Assets (M) (on 2014-12-31) 935.2762
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 1.47
Average 52-Week % Premium 0.9637
Fund Leveraged N

Dividends for DANIBIO

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-04-25) 12.8000
Dividend Yield (ttm) 4.20%

Performance for DANIBIO

1-Month +13.87% 1-Year +71.54%
3-Month +20.87% 3-Year +46.32%
Year To Date +13.87% 5-Year +34.55%
Expense Ratio 1.50

Top Fund Holdings for DANIBIO

Filing Date: 09/30/2014
Name Position Value % of Total
InterMune Inc 127,510 55,519,334 7.731%
United Therapeutics Corp 58,948 44,688,234 6.223%
Pharmacyclics Inc 56,622 39,181,278 5.456%
BioMarin Pharmaceutical Inc 91,050 38,716,029 5.391%
Amgen Inc 45,531 37,685,492 5.248%
Gilead Sciences Inc 59,985 37,627,266 5.240%
Exact Sciences Corp 316,401 36,133,161 5.032%
Regeneron Pharmaceuticals Inc 16,685 35,446,218 4.936%
Vertex Pharmaceuticals Inc 53,508 35,412,083 4.931%
Celgene Corp 63,351 35,382,174 4.927%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil